IESS Secures HIV Treatment with $868,000 Investment

The Ecuadorian Social Security Institute (IESS) is ensuring the continuous supply of antiretroviral drugs for its HIV-positive patients through a significant international procurement. The institute invested over $868,000 via the Pan American Health Organization (PAHO) to secure these vital medications.

This strategic acquisition guarantees an 18-month supply of treatment regimens, preventing interruptions in patient care. The first shipment, containing 258,240 tablets across five different medications, arrived in Ecuador and began distribution to IESS health facilities on June 12, 2026. Additional shipments are expected in the coming weeks to bolster the national drug inventory.

IESS maintains a robust network for managing HIV care, including 11 comprehensive care units and 10 health centers focused on Pre-Exposure Prophylaxis (PrEP). These facilities are strategically located across key provinces, offering not only medication but also integrated support services. These include early diagnosis, viral load monitoring, specialized human-centered medical attention, and preventive actions aimed at reducing HIV transmission among insured individuals.